ATAI Life Sciences Successfully Closes $43 Million Series B Financing Round
NEW YORK & LONDON & BERLIN--(BUSINESS WIRE)--Mar 27, 2019--ATAI Life Sciences, the global biotech platform dedicated to curing mental health disorders, has completed its series B f…